AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...
During the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago from Nov. 25 to 30, GE Healthcare announced the receipt of U.S. Food and Drug ...
MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a community announcement. Y-90 radioembolization is a minimally invasive procedure ...
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according ...
First global Phase III trial to show improved clinical outcome for systemic therapy in combination with transarterial chemoembolization (TACE) in this setting WILMINGTON, Del.--(BUSINESS WIRE)-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results